Current:Home > StocksBeyond Condoms! -AssetVision
Beyond Condoms!
View
Date:2025-04-16 04:56:30
Contraceptive research has historically prioritized women because they bear the burden of pregnancy and most contraceptive options available today are for women. But there are efforts to widen the contraceptive responsibility.
Researchers are looking into both hormonal and non-hormonal male contraceptives. They hope that at least one of the products will hit the market in the next decade. "An optimistic but still realistic timeline is in the order of 7 to 10 years," says Dr. Stephanie Page, a researcher at the University of Washington School of Medicine and lead investigator within the Contraceptive Clinical Trials Network.
Today, Scientist-in-Residence Regina G. Barber talks to host Emily Kwong about the state of research into male contraceptives and which method is expected to hit the market first.
We're always excited to hear what's on our listeners' minds. You can reach the show by emailing shortwave@npr.org.or tweeting us @NPRShortWave.
This episode was produced by Rebecca Ramirez, edited by Gisèle Grayson and fact-checked by Abē Levine. Tre Watson was the audio engineer.
veryGood! (46719)
Related
- Juan Soto to be introduced by Mets at Citi Field after striking record $765 million, 15
- New Mexico attorney general sues company behind Snapchat alleging child sexual extortion on the site
- Magic Johnson buys a stake in the NWSL’s Washington Spirit
- USWNT star Alex Morgan announces retirement from soccer, second pregnancy
- Kylie Jenner Shows Off Sweet Notes From Nieces Dream Kardashian & Chicago West
- 'Joker 2' is 'startlingly dull' and Lady Gaga is 'drastically underused,' critics say
- National Cheese Pizza Day: Where to get deals and discounts on Thursday
- Ticketmaster’s pricing for Oasis tickets is under investigation in the UK
- Backstage at New York's Jingle Ball with Jimmy Fallon, 'Queer Eye' and Meghan Trainor
- 3 Milwaukee police officers and a suspect are wounded in a shootout
Ranking
- Federal hiring is about to get the Trump treatment
- Christina Hall Stresses Importance of Making Her Own Money Amid Josh Hall Divorce
- Selling Sunset's Chrishell Stause Says She Has Receipts on Snake Nicole Young
- Taylor Swift Arrives in Style to Travis Kelce's First NFL Game Since Kansas City Chiefs' Super Bowl Win
- $73.5M beach replenishment project starts in January at Jersey Shore
- Alex Morgan retires from professional soccer and is expecting her second child
- Defensive coordinator Richard Aspinwall among 4 killed in Georgia high school shooting
- Courtroom clash in Trump’s election interference case as the judge ponders the path ahead
Recommendation
Intel's stock did something it hasn't done since 2022
Rift between Parkland massacre survivor and some families of the dead erupts in court
Gov. Ivey asks state veteran affairs commissioner to resign
Trump lawyers fight to overturn jury’s finding that he sexually abused E. Jean Carroll
Federal appeals court upholds $14.25 million fine against Exxon for pollution in Texas
Federal judge asked to give preliminary OK to $2.78 billion settlement of NCAA antitrust claims
Giants reward Matt Chapman's bounce-back season with massive extension
Colt Gray, 14, identified as suspect in Apalachee High School shooting: What we know